Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct;17(5):1471-1479.
doi: 10.1007/s11764-022-01178-z. Epub 2022 Feb 4.

Needs and preferences of breast cancer survivors regarding outcome-based shared decision-making about personalised post-treatment surveillance

Jet W Ankersmid  1   2 , Constance H C Drossaert  3 , Yvonne E A van Riet  4 , Luc J A Strobbe  5 , Sabine Siesling  6   7 ; Santeon VBHC Breast Cancer Group
Affiliations

Needs and preferences of breast cancer survivors regarding outcome-based shared decision-making about personalised post-treatment surveillance

Jet W Ankersmid et al. J Cancer Surviv. 2023 Oct.

Abstract

Purpose: In this study, we explored how patients experience current information provision and decision-making about post-treatment surveillance after breast cancer. Furthermore, we assessed patients' perspectives regarding less intensive surveillance in case of a low risk of recurrence.

Methods: We conducted semi-structured interviews with 22 women in the post-treatment surveillance trajectory in seven Dutch teaching hospitals.

Results: Although the majority of participants indicated a desire for shared decision-making (SDM) about post-treatment surveillance, participants experienced no SDM. Information provision was often suboptimal and unstructured. Participants were open for using risk information in decision-making, but hesitant towards less intensive surveillance. Perceived advantages of less intensive surveillance were: less distressing moments, leaving the patient role behind, and lower burden. Disadvantages were: fewer moments for reassurance, fear of missing recurrences, and a higher threshold for aftercare for side effects.

Conclusions: SDM about post-treatment surveillance is desirable. Although women are hesitant about less intensive surveillance, they are open to the use of personalised risk assessment for recurrences in decision-making about surveillance.

Implications for cancer survivors: To facilitate SDM about post-treatment surveillance, the timing and content of information provision should be improved. Risk information should be provided in an accessible and understandable way. Moreover, fear of cancer recurrence and other personal considerations should be addressed in the process of SDM.

Keywords: Breast cancer; Follow-up; Personalised care; Risk information; Shared decision-making; Surveillance.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Overview of main themes and subthemes
See this image and copyright information in PMC

References

    1. Integraal Kankercentrum Nederland (IKNL). NKR cijfers [NCR numbers] [Internet]. Available from: https://www.iknl.nl/nkr-cijfers
    1. NABON. Breast cancer - Dutch Guideline, version 2.0. Oncoline. 2012.
    1. Witteveen A, Munck L, Groothuis‐Oudshoorn CGM, Sonke GS, Poortmans PM, Boersma LJ, et al. Evaluating the age‐based recommendations for long‐term follow‐up in breast cancer. Oncologist [Internet]. 2020 Sep 29; 25(9):e1330–8. Available from: https://onlinelibrary.wiley.com/doi/10.1634/theoncologist.2019-0973 - DOI - PMC - PubMed
    1. Høeg BL, Bidstrup PE, Karlsen R V., Friberg AS, Albieri V, Dalton SO, et al. Follow-up strategies following completion of primary cancer treatment in adult cancer survivors. Cochrane Database Syst Rev [Internet]. 2019 Nov 21; 2019(11). Available from: http://doi.wiley.com/10.1002/14651858.CD012425.pub2 - DOI - PMC - PubMed
    1. Lafranconi A, Pylkkänen L, Deandrea S, Bramesfeld A, Lerda D, Neamțiu L, et al. Intensive follow-up for women with breast cancer: review of clinical, economic and patient’s preference domains through evidence to decision framework. Health Qual Life Outcomes [Internet]. 2017; 15(1):206. Available from: http://hqlo.biomedcentral.com/articles/10.1186/s12955-017-0779-5 - DOI - PMC - PubMed

Publication types